ZYN002 Transdermal Gel Cannabidiol (CBD) clinical trials

An Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults with Fragile X Syndrome

This study looks at the long-term safety of a CBD gel for children, teenagers, and young adults with Fragile X Syndrome. It also checks if the gel helps with common symptoms like irritability and social difficulties over time.